Suven Pharmaceuticals Ltd News
Suven Pharma shares jump 6% after topline zooms 11% in Q2 earnings
Shares of Suven Pharmaceuticals surged up to 6.25 per cent at Rs 1,279 per share on the BSE in Wednesday's intraday deals
 "Suven Pharma shares jump 6% after topline zooms 11% in Q2 earnings")
Suven, Cohance aim to double combined biz revenue to Rs 6,000 cr by FY29
Merger-bound Suven Pharmaceuticals and Cohance Lifesciences aim to more than double their combined revenue to around Rs 6,000 crore by FY29 by undertaking both organic and inorganic growth routes, a top company official said. The entities reported a combined revenue of Rs 2,392 crore in FY24. The merged entity aims to put in place an aggressive plan to more than double revenue to Rs 6,000 crore by FY29 through both organic and inorganic growth routes, Suven Pharma Managing Director Prasada Raju said. The merger between Suven and Cohance has received approval from both NSE & BSE. As directed by National Company Law Tribunal (NCLT), the shareholders meeting of both Suven Pharmaceuticals and Cohance Lifesciences amalgamation will be held on November 28, 2024. Once finalised and approved, the combined entity will focus on three core growth drivers: pharma CDMO, specialty chemicals CDMO, and active pharmaceutical ingredients (APIs). "Together, we're building a powerhouse poised to ...
 "Suven, Cohance aim to double combined biz revenue to Rs 6,000 cr by FY29")
Suven Pharma hits record high on USFDA's 'VAI' tag to Hyderabad facility
Suven Pharmaceuticals share price surged up to 3.67 per cent, hitting their all time high at Rs 1,245 per share on the BSE on Monday
 "Suven Pharma hits record high on USFDA's 'VAI' tag to Hyderabad facility")
Suven Pharma, Max Health can rally up to 9%: Angel One
Rajesh Bhosale, Equity Technical Analyst at Angel One, expects the Nifty to move in the this 23,200 - 23,600 range this week.
 "Suven Pharma, Max Health can rally up to 9%: Angel One")
